Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 6,590,000 | 7,244,000 | 7,421,000 | 6,217,000 | 6,423,000 |
| Cost of Goods | 1,424,000 | 2,627,000 | 1,223,000 | 1,390,000 | 1,361,000 |
| Gross Profit | 5,166,000 | 4,617,000 | 6,198,000 | 4,827,000 | 5,062,000 |
| Operating Expenses | 4,969,000 | 3,677,000 | 2,356,000 | 2,581,000 | 2,172,000 |
| Operating Income | 197,000 | 940,000 | 3,842,000 | 2,246,000 | 2,890,000 |
| Interest Expense | 238,000 | 238,000 | 250,000 | 256,000 | 257,000 |
| Other Income | -111,000 | 57,000 | -154,000 | -173,000 | -369,000 |
| Pre-tax Income | -152,000 | 759,000 | 3,438,000 | 1,817,000 | 2,264,000 |
| Income Tax | -164,000 | 383,000 | 852,000 | 300,000 | 542,000 |
| Net Income Continuous | 12,000 | 376,000 | 2,586,000 | 1,517,000 | 1,722,000 |
| Minority Interests | -7,000 | -6,000 | -6,000 | -5,000 | -7,000 |
| Net Income | $19,000 | $382,000 | $2,592,000 | $1,522,000 | $1,729,000 |
| EPS Basic Total Ops | 0.02 | 0.31 | 2.06 | 1.21 | 1.38 |
| EPS Basic Continuous Ops | 0.01 | 0.30 | 2.06 | 1.21 | 1.37 |
| EPS Diluted Total Ops | 0.02 | 0.30 | 2.05 | 1.21 | 1.37 |
| EPS Diluted Continuous Ops | 0.01 | 0.30 | 2.05 | 1.20 | 1.36 |
| EBITDA(a) | $722,000 | $1,475,000 | $4,365,000 | $2,765,000 | $3,363,000 |